Emend (Aprepitant Oral Suspension) and Trastuzumab and Hyaluronidase
Determining the interaction of Emend (Aprepitant Oral Suspension) and Trastuzumab and Hyaluronidase and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Emend, Cinvanti, Emend 3-Day, Emend 2-Day
Synonyms: Emend
Generic Name: hyaluronidase / trastuzumab
Brand name: Herceptin Hylecta
Synonyms: Hyaluronidase and trastuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emend (Aprepitant Oral Suspension)-Trastuzumab Injection (Intravenous)
- Emend (Aprepitant Oral Suspension)-Trastuzumab Intravenous
- Emend (Aprepitant Oral Suspension)-Trastuzumab-anns
- Emend (Aprepitant Oral Suspension)-Trastuzumab-dkst
- Emend (Aprepitant Oral Suspension)-Trastuzumab-dkst Intravenous
- Emend (Aprepitant Oral Suspension)-Trasylol
- Trastuzumab and Hyaluronidase-Emend (Fosaprepitant)
- Trastuzumab and Hyaluronidase-Emend for Injection
- Trastuzumab and Hyaluronidase-Emend Intravenous
- Trastuzumab and Hyaluronidase-Emflaza
- Trastuzumab and Hyaluronidase-Emflaza (Deflazacort Oral Suspension)
- Trastuzumab and Hyaluronidase-Emflaza (Deflazacort Tablets)